Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
As communicated several times, latest in Company announcement 12/2023, Orphazyme is part of a US class action lawsuit. The court has granted preliminary approval of the proposed settlement and...
-
As mentioned in announcement 11/2023 the Company and CEO/CFO Anders Fink Vadsholt entered into a severance agreement at May 30th 2023, where Mr. Vadsholt would step down as CEO/CFO of the Company no...
-
Business updates and Financial highlights First Half 2023:Unless otherwise stated, comments in this announcement refer to H1 performance from continuing operations. In 2022, the business operations...
-
The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as CEO/CFO of the Company. Regardless, Mr. Vadsholt...
-
Company announcement No. 10/2023 Orphazyme A/S Ole Maaløes Vej 3DK-2200 Copenhagen N www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, May 19, 2023 –...
-
Company announcement Orphazyme A/SNo. 09/2023 Ole Maaløes Vej 3DK-2200 Copenhagen N www.orphazyme.comCompany Registration No. 32266355 Major shareholder announcement ...
-
Company announcement Orphazyme A/SNo. 8/2023 Ole Maaløes Vej 3DK-2200 Copenhagen N ...
-
Company announcement Orphazyme A/SNo....
-
Company announcement Orphazyme A/SNo....
-
Company announcement Orphazyme A/SNo....